Stock & Company Details
Aptevo Therapeutics Inc $APVO
Price:
N/A
N/A
1.8M
$3.3M
52 Week High:
N/A
10 Day Average Volume:
N/A
-0.01
50 Day Moving Average:
N/A
52 Week Low:
N/A
30 Day Average Volume:
N/A
N/A
N/A
N/A
30 Day Change:
N/A
3 Month Change:
N/A
Health Technology
APVO technical indicators
Latest Aptevo Therapeutics Inc (APVO) indicator readings as of 2026-10-08.
APVO's 14-day RSI is 36.6, in neutral territory. ADX reads 32.6, indicating a trending market. MACD (12, 26, 9) is -0.18, below the zero line.
Overview
Aptevo Therapeutics Inc. is a clinical-stage biotechnology company focused on developing novel immunotherapies for the treatment of cancer. The Company's lead clinical candidate, APVO436, and preclinical candidates, ALG.APV-527 and APVO603, were developed based on the Company's versatile and robust ADAPTIR™ modular protein technology platform. The ADAPTIR™ platform is capable of generating highly differentiated bispecific antibodies with unique mechanisms of action for the treatment of different types of cancer.
Finance Bot
Ask your questions
Start by typing a question below.
